Showing 1 - 10 of 24
In 2003 a new type of provider organisation, the Foundation Trust (FT), was introduced in England, and the best performing NHS hospitals were able to apply for 'Foundation status'. FTs enjoy greater financial flexibility and are subject to less central monitoring and control. The phased...
Persistent link: https://www.econbiz.de/10005694168
In recent years there have been marked changes in organisational structures and budgetary arrangements in the English National Health Service, potentially altering the relationships between purchasers (primary care organisations (PCOs) and general practices) and hospitals. We show that elective...
Persistent link: https://www.econbiz.de/10005689891
Persistent link: https://www.econbiz.de/10012406847
The Labour government has outlined its plans to 'replace' the competitive internal market with a more collaborative system based on partnership. Agreement amongst purchasers and providers is to be based on co-operation rather than competition. Longer term agreements covering periods of 3-5 years...
Persistent link: https://www.econbiz.de/10005694063
Purchasers and providers in the National Health Service (NHS) are now required to move from annual contracting cycles to longer-term contracts. The benefits are expected to include more efficient investment and improved sharing of financial risk. This paper argues that the economic analysis of...
Persistent link: https://www.econbiz.de/10005792765
This paper examines the role of information in securing control of health care systems. The discussion focuses on the impact of the proposed 'Performance Framework', which entails a significant increase in the importance attached to formal performance indicators in the management of the UK...
Persistent link: https://www.econbiz.de/10005792801
Persistent link: https://www.econbiz.de/10012082336
Persistent link: https://www.econbiz.de/10012082416
Persistent link: https://www.econbiz.de/10011005285
When health effects can be valued in monetary terms, as in cost-benefit analysis, they should be discounted at the same rate as costs. If health effects are measured in quantities (e.g. quality adjusted life years) as in cost-effectiveness analysis (CEA) and the value of health effects is...
Persistent link: https://www.econbiz.de/10005200032